DROXIDOPA
Generic: DROXIDOPA
Lupin PharmaceuticalsManufacturer
ORALRoute
DROXIDOPAActive Substance
2021-02-18Original Approval
DROXIDOPA is FDA application ANDA211652, sponsored by LUPIN PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DEATH
253 reports
2
FALL
159 reports
3
DIZZINESS
97 reports
4
HALLUCINATION
91 reports
5
DRUG INEFFECTIVE
78 reports
6
HYPOTENSION
78 reports
7
LOSS OF CONSCIOUSNESS
66 reports
8
HOSPITALISATION
61 reports
9
CONFUSIONAL STATE
53 reports
10
PRODUCT DOSE OMISSION ISSUE
49 reports